GLPG

Galapagos NV (GLPG)

Galapagos NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GLPG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 01	GlobeNewswire Inc.	Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024	NASDAQ:GLPG	Galapagos NV
2024/05/31	05 : 44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/31	05 : 01	GlobeNewswire Inc.	Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications	NASDAQ:GLPG	Galapagos NV
2024/05/17	05 : 28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/17	05 : 01	GlobeNewswire Inc.	Galapagos creates new subscription right plans	NASDAQ:GLPG	Galapagos NV
2024/05/16	21 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/05/16	05 : 01	GlobeNewswire Inc.	Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.	NASDAQ:GLPG	Galapagos NV
2024/05/03	05 : 01	GlobeNewswire Inc.	Galapagos reports first quarter 2024 financial results	NASDAQ:GLPG	Galapagos NV
2024/05/01	05 : 01	GlobeNewswire Inc.	Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	NASDAQ:GLPG	Galapagos NV
2024/04/05	05 : 01	GlobeNewswire Inc.	Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	NASDAQ:GLPG	Galapagos NV
2024/03/29	05 : 01	GlobeNewswire Inc.	Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	NASDAQ:GLPG	Galapagos NV
2024/03/27	05 : 01	GlobeNewswire Inc.	Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board	NASDAQ:GLPG	Galapagos NV
2024/02/23	20 : 41	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/02/23	06 : 01	GlobeNewswire Inc.	Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline	NASDAQ:GLPG	Galapagos NV
2024/02/23	06 : 01	GlobeNewswire Inc.	Galapagos announces full year 2023 results and outlook for 2024	NASDAQ:GLPG	Galapagos NV
2024/02/16	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/02/16	06 : 01	GlobeNewswire Inc.	Galapagos presents at EBMT-EHA annual meeting 2024	NASDAQ:GLPG	Galapagos NV
2024/02/15	07 : 41	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GLPG	Galapagos NV
2024/02/01	06 : 01	GlobeNewswire Inc.	Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	NASDAQ:GLPG	Galapagos NV
2024/01/05	06 : 44	Dow Jones News	Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug	NASDAQ:GLPG	Galapagos NV
2024/01/05	06 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/01/05	06 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2024/01/05	06 : 01	GlobeNewswire Inc.	Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	NASDAQ:GLPG	Galapagos NV
2024/01/04	06 : 01	GlobeNewswire Inc.	Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology	NASDAQ:GLPG	Galapagos NV
2024/01/04	06 : 01	PR Newswire (US)	BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets	NASDAQ:GLPG	Galapagos NV
2024/01/02	15 : 00	GlobeNewswire Inc.	Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	NASDAQ:GLPG	Galapagos NV
2023/12/22	06 : 03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GLPG	Galapagos NV
2023/12/20	06 : 01	GlobeNewswire Inc.	Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301	NASDAQ:GLPG	Galapagos NV
2023/12/10	02 : 00	GlobeNewswire Inc.	Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101	NASDAQ:GLPG	Galapagos NV
2023/12/08	06 : 01	GlobeNewswire Inc.	Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023	NASDAQ:GLPG	Galapagos NV